Previous studies have shown that CENPK is abnormally up-regulated in a variety of tumor tissues and cells, and has been used as a new tumor marker in a variety of cancers such as hepatocellular carcinoma and ovarian cancer [35, 38–40]. The gene discussed is CENPK; the disease is ovarian cancer.